United States ex rel. Streck v. Bristol-Myers Squibb Co.
District Court, E.D. Pennsylvania
1Opinion of the Court
Savage, District Judge.
Moving for reconsideration of the denial of its motion to dismiss the complaint, Bristol-Myers Squibb (BMS) contends that we erroneously determined that relator Ronald J. Streck adequately pled the falsity and knowledge elements of his "service fee scheme" claim under the False Claims Act (FCA), 31 U.S.C. § 3729 - 33. Recognizing *494that we could have been clearer, we now clarify the rationale for our ruling.
As alleged in Streck's amended complaint, BMS engaged in two schemes, each at different times, to fraudulently reduce the rebates it owed the states under the Medicaid…
2Cases cited8 opinions
- Safeco Insurance Co. of America v. BurrSupreme Court of the United States · 2007
- Universal Health Services, Inc. v. United States ex rel. EscobarSupreme Court of the United States · 2016
- Pharmaceutical Research and Manufacturers of America v. Walsh, Acting Commissioner, Maine Department of Human ServicesSupreme Court of the United States · 2003
- United States Ex Rel. Wilkins v. United Health Group, Inc.Court of Appeals for the Third Circuit · 2011
- United States Ex Rel. Petratos v. Genentech Inc.Court of Appeals for the Third Circuit · 2017
3 more not listed; retrieve them via the Exa API.
3Cited by14 opinions
- United States ex rel. Deborah Sheldon v. Allergan Sales, LLCCourt of Appeals for the Fourth Circuit · 2022
- United States ex rel. Deborah Sheldon v. Allergan Sales, LLCCourt of Appeals for the Fourth Circuit · 2022
- ARMSTRONG v. ANDOVER SUBACUTE AND REHAB CENTER SERVICES ONE, INC.District Court, D. New Jersey · 2020
- ARMSTRONG v. ANDOVER SUBACUTE AND REHAB CENTER SERVICES ONE, INC.District Court, D. New Jersey · 2019
- CLARK v. QUESTCOR PHARMACEUTICALS, INC.District Court, E.D. Pennsylvania · 2020
9 more not listed; retrieve them via the Exa API.